Viveca Nerme
Impact in
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Receptor Mechanisms and Signaling 8
-
- Pharmacological Effects and Assays 8
- Co-authors
- Tommy Abrahamsson (14 shared papers)Judith Leurs (3 shared papers)Dirk Hendriks (2 shared papers)Georges Vauquelin (5 shared papers)J.J.J. van Giezen (2 shared papers)Bengt Ek (1 shared paper)K. Schatteman (2 shared papers)Petter Björquist (2 shared papers)
- Journals
- Thrombosis and Haemostasis (4 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Biochemical Pharmacology (2 papers)Molecular Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- SwedenBelgiumUnited Kingdom
In The Last Decade
Viveca Nerme
22 papers receiving 478 citations
Peers
Comparison fields: 5 of 71
- Hematology 180
- Cancer Research 101
- Internal Medicine 19
- Genetics 53
- Cardiology and Cardiovascular Medicine 88
Countries citing papers authored by Viveca Nerme
This map shows the geographic impact of Viveca Nerme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viveca Nerme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viveca Nerme more than expected).
Fields of papers citing papers by Viveca Nerme
This network shows the impact of papers produced by Viveca Nerme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viveca Nerme. The network helps show where Viveca Nerme may publish in the future.
Co-authors
The 25 scholars most cited alongside Viveca Nerme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 91 | |
| 2 | 1997 | 44 | |
| 3 | 2003 | 39 | |
| 4 | 1996 | 34 | |
| 5 | 2015 | 32 | |
| 6 | 1990 | 30 | |
| 7 | 1988 | 27 | |
| 8 | 2012 | 26 | |
| 9 | 1987 | 25 | |
| 10 | 1985 | 23 | |
| 11 | 2002 | 22 | |
| 12 | 1990 | 21 | |
| 13 | 1984 | 18 | |
| 14 | 1998 | 18 | |
| 15 | 2005 | 17 | |
| 16 | 1990 | 13 | |
| 17 | 1994 | 10 | |
| 18 | 1986 | 8 | |
| 19 | 1986 | 7 | |
| 20 | 1987 | 3 |
About Viveca Nerme
Viveca Nerme is a scholar working on Molecular Biology, Animal Science and Zoology, Hematology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 512 indexed citations. Recurring topics across this work include Pharmacological Effects and Assays (8 papers), Receptor Mechanisms and Signaling (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Protease and Inhibitor Mechanisms (6 papers), Neuroscience and Neuropharmacology Research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Cell Adhesion Molecules Research (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Hematology (180 citations), Cancer Research (101 citations), Internal Medicine (19 citations), Genetics (53 citations) and Cardiology and Cardiovascular Medicine (88 citations). Viveca Nerme has collaborated with scholars based in Sweden, Belgium and United Kingdom. Frequent co-authors include Tommy Abrahamsson, Judith Leurs, Dirk Hendriks, Georges Vauquelin, J.J.J. van Giezen, Bengt Ek, K. Schatteman, Petter Björquist, Per‐Ove Sjöquist and Anders Hedberg. Their work appears in journals such as Thrombosis and Haemostasis, Naunyn-Schmiedeberg s Archives of Pharmacology, Biochemical Pharmacology, Molecular Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.